1. bookVolume 50 (2016): Issue 2 (April 2016)
Journal Details
License
Format
Journal
eISSN
1336-0329
First Published
30 Mar 2016
Publication timeframe
4 times per year
Languages
English
access type Open Access

Role of interlekin-35 as a biomarker in patients with newly diagnosed Hashimoto’s thyroiditis

Published Online: 18 May 2016
Volume & Issue: Volume 50 (2016) - Issue 2 (April 2016)
Page range: 55 - 61
Journal Details
License
Format
Journal
eISSN
1336-0329
First Published
30 Mar 2016
Publication timeframe
4 times per year
Languages
English
Abstract

Objective. Interleukin-35 (IL-35), an interleukin-12 (IL-12) cytokine family member, is shown to be a potent immunosuppressive and anti-inflammatory cytokine. Inducible regulatory T cells (Tregs) produce IL-35 that mediates the immune inhibitory function of Tregs. Growing evidence revealed that upregulation of IL-35 expression may play a critical role in the prevention of autoimmune diseases in various experimental autoimmunity models and vice versa. Hashimoto’s thyroiditis (HT) is considered to be a Treg cell-related autoimmune disease with loss of self-tolerance.

Methods. One hundred-twenty eight subjects, newly diagnosed hypothyroid HT patients [56 overt (Group 1), 72 subclinical hypothyroid (Group 2)] and 38 healthy controls (Group 3) were enrolled in the study. The levels of serum IL-35 were determined by enzyme-linked immunosorbent assay (ELISA).

Results. Serum IL-35 levels were lower in the HT group when compared with subclinical HT group [304.5 (834.6) pg/ml vs. 636.1 (1542.0) pg/ml, p=0.004] and control cases [304.5 (834.6) pg/ml vs. 1064.7 (2526.8) pg/ml, p<0.001]. Serum IL-35 levels were inversely associated with thyroid stimulating hormone (TSH; rs=-0.396, p<0.001) and anti-thyroid peroxidase antibodies (TPOAb; rs=-0.571, p<0.001) in whole group. Serum IL-35 were negatively associated with TSH (rs=-0.264, p=0.003) and TPOAb (rs=-0.735, p<0.001) in patients with Hashimoto’s thyroiditis (Group 1 + Group 2).

Conclusion. The results suggest that IL-35 may play a role in the pathogenesis of HT.

Keywords

Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, Zoll J, Merval R, Esposito B, Cohen JL, Fisson S, Flavell RA, Hansson GK, Klatzmann D, Tedgui A, Mallat Z. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 12, 178-180, 2006.10.1038/nm134316462800Search in Google Scholar

Akinci B, Comlekci A, Yener S, Bayraktar F, Demir T, Ozcan MA, Yuksel F, Yesil S. Hashimoto’s thyroiditis, but not treatment of hypothyroidism, is associated with altered TGFbeta1 levels. Arch Med Res 39, 397-401, 2008.10.1016/j.arcmed.2007.12.00118375250Search in Google Scholar

Bettini M, Castellaw AH, Lennon GP, Burton AR, Vignali DA. Prevention of autoimmune diabetes by ectopic pancreatic β-cell expression of interleukin-35. Diabetes 61, 1519-1526, 2012.10.2337/db11-0784335727722427377Search in Google Scholar

Bossowski A, Moniuszko M, Dąbrowska M, Sawicka B, Rusak M, Jeznach M, Wojtowicz J, Bodzenta-Lukaszyk A, Bossowska A. Lower proportions of CD4+CD25(high) and CD4+FoxP3, but not CD4+CD25+CD127(low) FoxP3+ T cell levels in children with autoimmune thyroid diseases. Autoimmunity 46, 222-230, 2013.10.3109/08916934.2012.75198123249428Search in Google Scholar

Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev 13, 391-397, 2014.10.1016/j.autrev.2014.01.00724434360Search in Google Scholar

Chardes T, Chapal N, Bresson D, Bes C, Giudicelli V, Lefranc MP, Peraldi-Roux S. Th e human anti-thyroid peroxidase autoantibody repertoire in Graves’ and Hashimoto’s autoimmune thyroid diseases. Immunogenetics 54, 141-157, 2002.10.1007/s00251-002-0453-912073143Search in Google Scholar

Chaturvedi V, Collison LW, Guy CS, Workman CJ, Vignali DA. Cutting edge: Human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. J Immunol 186, 6661-6666, 2011.10.4049/jimmunol.1100315311056321576509Search in Google Scholar

Cogni G, Chiovato L. An overview of the pathogenesis of thyroid autoimmunity. Hormones (Athens) 12, 19-29, 2013.10.1007/BF0340128323624128Search in Google Scholar

Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS, Vignali DA. Th e inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450, 566-569, 2007.10.1038/nature0630618033300Search in Google Scholar

Collison LW, Vignali DA. Interleukin-35: odd one out or part of the family? Immunol Rev 226, 248-262, 2008.10.1111/j.1600-065X.2008.00704.x263136319161429Search in Google Scholar

Collison LW, Pillai MR, Chaturvedi V, Vignali DA. Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner. J Immunol 182, 6121-6128, 2009.10.4049/jimmunol.0803646269899719414764Search in Google Scholar

Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, Bankoti J, Finkelstein D, Forbes K, Workman CJ, Brown SA, Rehg JE, Jones ML, Ni HT, Artis D, Turk MJ, Vignali DA. IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 11, 1093-1101, 2010.10.1038/ni.1952300839520953201Search in Google Scholar

Effraimidis G, Wiersinga WM. Mechanisms in endocrinology: autoimmune thyroid disease: old and new players. Eur J Endocrinol 170, R241-R252, 2014.10.1530/EJE-14-004724609834Search in Google Scholar

Fehervari Z, Sakaguchi S. CD4+ Tregs and immune control. J Clin Invest 114, 1209-1217, 2004.10.1172/JCI200423395Search in Google Scholar

Gangi E, Vasu C, Cheatem D, Prabhakar BS. IL-10-producing CD4+ CD25 + regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis. J Immunol 174, 7006-7013, 2005.10.4049/jimmunol.174.11.700615905543Search in Google Scholar

Giordano C, Richiusa P, Bagnasco M, Pizzolanti G, Di Blasi F, Sbriglia MS, Mattina A, Pesce G, Montagna P, Capone F, Misiano G, Scorsone A, Pugliese A, Galluzzo A. Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease. Thyroid 11, 233-244, 2001.10.1089/10507250175015961511327614Search in Google Scholar

Gutekunst R, Smolarek H, Hasenpusch U, et al. Goiter epidemiology: thyroid volume, iodine excretion, thyroglobulin and thyrotropin in Germany and Sweden. Acta Endocrinol (Copenh) 112, 494-501, 1986.10.1530/acta.0.11204943529785Search in Google Scholar

Gutekunst R, Martin-Teichert H. Requirements for goiter surveys and the determination of thyroid size. In: Iodine Deficiency in Europe. A Continuing Concern. Delange F, Dunn JT, Glinoer D. Eds. New York: Plenum Press 1993, 109-118.10.1007/978-1-4899-1245-9_12Search in Google Scholar

Jacobson EM, Tomer Y. Th e genetic basis of thyroid autoimmunity. Thyroid 17, 949-961, 2007.10.1089/thy.2007.015317824829Search in Google Scholar

Kochetkova I, Golden S, Holderness K, Callis G, Pascual DW. IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10. J Immunol 184, 7144-7153, 2010.10.4049/jimmunol.0902739314577520483737Search in Google Scholar

Lewis E, Braverman RD. Werner & Ingbar’s the thyroid: a fundamental and clinical text (10th ed.). Philadelphia: Lippincott Williams & Wilkins. Chapter 4B, Kopp P 48-74, 2013.Search in Google Scholar

Nicholl MB, Ledgewood CL, Chen X, Bai Q, Qin C, Cook KM, Herrick EJ, Diaz-Arias A, Moore BJ, Fang Y. IL-35 promotes pancreas cancer growth through enhancement of proliferation and inhibition of apoptosis: evidence for a role as an autocrine growth factor. Cytokine 70, 126-133, 2014.10.1016/j.cyto.2014.06.02025073578Search in Google Scholar

Niedbala W, Wei XQ, Cai B, Hueber AJ, Leung BP, McInnes IB, Liew FY. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th 17 cells. Eur J Immunol 37, 3021-3029, 2007.10.1002/eji.20073781017874423Search in Google Scholar

Olson BM, Sullivan JA, Burlingham WJ. Interleukin 35: key mediator of suppression and the propagation of infectious tolerance. Front Immunol 4, 315, 2013.10.3389/fimmu.2013.00315379878224151492Search in Google Scholar

Pellerin L, Jenks JA, Begin P, Bacchetta R, Nadeau KC. Regulatory T cells and their roles in immune dysregulation and allergy. Immunol Res 58, 358-368, 2014.10.1007/s12026-014-8512-5416146224781194Search in Google Scholar

Shevach EM. Mechanisms of foxp3 + T regulatory cell mediated suppression. Immunity 30, 636-645, 2009.10.1016/j.immuni.2009.04.01019464986Search in Google Scholar

Stathatos N, Daniels GH. Autoimmune thyroid disease. Curr Opin Rheumatol 24, 70-75, 2012.10.1097/BOR.0b013e32834ddb2722157414Search in Google Scholar

Stojanovic J, Srefanovic D, Vulovic D, Puskas L, Markovic L. Role of apoptosis in pathogenesis of thyroiditis. Med Pregl 62, 49-52, 2009.10.2298/MPNS0902049SSearch in Google Scholar

Vural P, Degirmencioglu S, Erden S, Gelincik A. Th e relationship between transforming growth factor-beta1, vascular endothelial growth factor, nitric oxide and Hashimoto’s thyroiditis. Int Immunopharmacol 9, 212-215, 2009.10.1016/j.intimp.2008.11.00319028605Search in Google Scholar

Wang SH, Chen GH, Fan Y, Van Antwerp M, Baker JR Jr. Tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis by the expansion of CD4 + CD25 + regulatory T cells. Endocrinology 150, 2000-2007, 2009.10.1210/en.2008-1389265928619008314Search in Google Scholar

Wang RX, Yu CR, Dambuza IM, Mahdi RM, Dolinska MB, Sergeev YV, Wingfield PT, Kim SH, Egwuagu CE. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat Med 20, 633-641, 2014.10.1038/nm.3554404832324743305Search in Google Scholar

Whitehead GS, Wilson RH, Nakano K, Burch LH, Nakano H, Cook DN. IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J Allergy Clin Immunol 129, 207-215.e1-5, 2012.10.1016/j.jaci.2011.08.009326913521906794Search in Google Scholar

Wirtz S, Billmeier U, McHedlidze T, Blumberg RS, Neurath MF. Interleukin-35 Mediates Mucosal Immune Responses that Protect Against T Cell-Dependent Colitis. Gastroenterology 141, 1875-1886, 2011.10.1053/j.gastro.2011.07.040362489221820391Search in Google Scholar

Yu S, Fang Y, Sharp GC, Braley-Mullen H. Transgenic expression of TGF-beta on thyrocytes inhibits development of spontaneous autoimmune thyroiditis and increases regulatory T cells in thyroids of NOD.H-2h4 mice. J Immunol 184, 5352-5359, 2010.10.4049/jimmunol.0903620327227520335535Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo